Dennis Podlesak
Chairman at ADYNXX, INC.
Net worth: 2 M $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Eckard Weber | M | 73 |
Calixa Therapeutics, Inc.
 Calixa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Calixa Therapeutics, Inc. develops and commercializes hospital-based anti-infective therapies. The company was founded by Eckard Weber and James Ge in 2007 and is headquartered in San Diego, CA.
Peninsula Pharmaceuticals, Inc.
 Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Peninsula Pharmaceuticals, Inc. used to develop and commercialize antibiotics to treat life threatening infections. The company used to develop optimal anti-infective therapies that offer improved efficacy, dosing and safety characteristics over existing therapies. It was founded in 2001. The company was located in Alameda, CA.
Cerexa, Inc.
 Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA.
Transposon Therapeutics, Inc.
 Transposon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Transposon Therapeutics, Inc. provides pharmaceutical products. The company is headquartered in Westport, CT.
Domain Associates LLC
 Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey. | 23 years |
| Keith Katkin | M | 52 |
Peninsula Pharmaceuticals, Inc.
Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Peninsula Pharmaceuticals, Inc. used to develop and commercialize antibiotics to treat life threatening infections. The company used to develop optimal anti-infective therapies that offer improved efficacy, dosing and safety characteristics over existing therapies. It was founded in 2001. The company was located in Alameda, CA.
Transposon Therapeutics, Inc.
Transposon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Transposon Therapeutics, Inc. provides pharmaceutical products. The company is headquartered in Westport, CT. | 21 years |
| Michael Metzger | M | 53 | 9 years | |
| Stanley Abel | M | - |
Cerexa, Inc.
Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA.
Peninsula Pharmaceuticals, Inc.
Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Peninsula Pharmaceuticals, Inc. used to develop and commercialize antibiotics to treat life threatening infections. The company used to develop optimal anti-infective therapies that offer improved efficacy, dosing and safety characteristics over existing therapies. It was founded in 2001. The company was located in Alameda, CA. | 21 years |
| Rick Orr | M | - |
Cerexa, Inc.
Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA. | 14 years |
| Kim Kamdar | M | 56 |
Domain LLC
 Domain LLC Investment ManagersFinance Domain LLC provides investment advice.
Domain Associates LLC
Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey. | 19 years |
| Julien Mamet | M | - | 17 years | |
| Matthew Ruth | M | - | 5 years | |
| Keith Goldan | M | 52 | 2 years | |
| Pierre Legault | M | 63 | 7 years | |
| William Martin | M | - | 12 years | |
| Neil Gallagher | M | 60 | 1 years | |
| Martin Huber | M | 64 | 3 years | |
| Peter Ordentlich | M | 55 | 19 years | |
| William Meury | M | 56 | 6 years | |
| Jennifer Jarrett | F | 53 | 6 years | |
| Lisa A. Kraeutler | F | - |
Domain Associates LLC
Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey. | - |
| Sharon P. Klahre | F | - | 2 years | |
| Dina Gonzalez | F | - | 14 years | |
| Luke Albrecht | M | 45 | 8 years | |
| Catherine Madigan | M | 52 | - | |
| Kevin McManus | M | - | 1 years | |
| Hisanori Maei | M | - | 9 years | |
| Aneta Ferguson | F | - | 9 years | |
| Anjali Ganguli | M | 48 | 9 years | |
| Robert Sedor | M | - | 9 years | |
| Bill Harrington | M | - |
Transposon Therapeutics, Inc.
Transposon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Transposon Therapeutics, Inc. provides pharmaceutical products. The company is headquartered in Westport, CT. | - |
| Daniel Hetu | M | - |
Transposon Therapeutics, Inc.
Transposon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Transposon Therapeutics, Inc. provides pharmaceutical products. The company is headquartered in Westport, CT. | - |
| James Blair | M | 84 |
Domain Associates LLC
Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey. | 39 years |
| Ashton Newhall | M | - |
Domain Associates LLC
Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey. | 18 years |
| Brian Halak | M | 52 |
Domain Associates LLC
Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey. | 23 years |
| John Pacifico | M | - |
Transposon Therapeutics, Inc.
Transposon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Transposon Therapeutics, Inc. provides pharmaceutical products. The company is headquartered in Westport, CT. | - |
| Brent Ahrens | M | 61 |
Transposon Therapeutics, Inc.
Transposon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Transposon Therapeutics, Inc. provides pharmaceutical products. The company is headquartered in Westport, CT. | - |
| Nicole Vitullo | F | 66 |
Domain Associates LLC
Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey. | 25 years |
| Brian H. Dovey | M | 83 |
Domain Associates LLC
Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey. | 36 years |
| BT Slingsby | M | - |
Transposon Therapeutics, Inc.
Transposon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Transposon Therapeutics, Inc. provides pharmaceutical products. The company is headquartered in Westport, CT. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Eric Brandt | M | 62 | 8 years | |
| Richard Shea | M | 72 | 6 years | |
| Allan Shaw | M | 59 | 1 years | |
| Ian Clements | M | 55 | 5 years | |
| Paul Truex | M | 55 |
Peninsula Pharmaceuticals, Inc.
Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Peninsula Pharmaceuticals, Inc. used to develop and commercialize antibiotics to treat life threatening infections. The company used to develop optimal anti-infective therapies that offer improved efficacy, dosing and safety characteristics over existing therapies. It was founded in 2001. The company was located in Alameda, CA. | 4 years |
| Briggs Morrison | M | 65 | 9 years | |
| Christine Ocampo | F | 51 | 8 years | |
| Patrick Heron | M | 53 |
Calixa Therapeutics, Inc.
Calixa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Calixa Therapeutics, Inc. develops and commercializes hospital-based anti-infective therapies. The company was founded by Eckard Weber and James Ge in 2007 and is headquartered in San Diego, CA.
Cerexa, Inc.
Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA. | 6 years |
| John S. Pallies | M | 60 | 9 years | |
| Rohan Palekar | M | 58 | 5 years | |
| Gregory P. Hanson | M | 77 | 8 years | |
| Alexander Nolte | M | 52 | 6 years | |
| Arlene Morris | F | 72 | 4 years | |
| Ambrose Bailey | M | 60 | - | |
| Joanna Horobin | M | 69 | 6 years | |
| Gerald Yakatan | M | 82 | 10 years | |
| Scott Whitcup | M | 64 | 15 years | |
| Caroline F. van Hove | F | 43 | 16 years | |
| Michael McFadden | M | 57 | 7 years | |
| Fabrice Egros | M | 62 | 9 years | |
| Joanna L. Moore | F | - | - | |
| Hans Bishop | M | 59 | 3 years | |
| Stephen Larson | M | 67 |
Western Illinois University
| 5 years |
| Carol Brosgart | M | 72 | 7 years | |
| Michael Meyers | M | 74 | 7 years | |
| George W. Sledge | M | 73 | 3 years | |
| Eric Benevich | M | 58 | 10 years | |
| Henry Chen | M | 53 | 3 years | |
| Stephen M. Kaufhold | M | - | - | |
| Keith M. McGahan | M | - | 1 years | |
| Dirk Thye | M | 54 |
Peninsula Pharmaceuticals, Inc.
Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Peninsula Pharmaceuticals, Inc. used to develop and commercialize antibiotics to treat life threatening infections. The company used to develop optimal anti-infective therapies that offer improved efficacy, dosing and safety characteristics over existing therapies. It was founded in 2001. The company was located in Alameda, CA. | 4 years |
| J. Michael Judy | M | - | 8 years | |
| David Mazzo | M | 67 | 10 years | |
| Gwen Melincoff | M | 72 | 2 years | |
| Mark Corrigan | M | 66 | 1 years | |
| Stephen J. Ryan | M | 83 | 11 years | |
| Abhay Joshi | M | 61 | 5 years | |
| Andrew Fromkin | M | 58 | 1 years | |
| Aimee Weisner | F | 55 | 4 years | |
| Craig Wheeler | M | 63 | 10 years | |
| Jeffrey Cooper | M | 68 | 1 years | |
| James Ge | M | - |
Calixa Therapeutics, Inc.
Calixa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Calixa Therapeutics, Inc. develops and commercializes hospital-based anti-infective therapies. The company was founded by Eckard Weber and James Ge in 2007 and is headquartered in San Diego, CA. | - |
| Stephen G. Austin | M | 71 | 9 years | |
| Luke Evnin | M | 60 | 6 years | |
| Ivor Royston | M | 79 | 4 years | |
| Laurent Fischer | M | 60 | 1 years | |
| Patrick O'Brien | M | - | 5 years | |
| Karen Osar | F | 74 | 7 years | |
| Vittorio Favati | M | 65 |
Western Illinois University
| 4 years |
| Thomas Kienzler | M | - |
Western Illinois University
| 4 years |
| Ron Murray | M | - |
Western Illinois University
| 4 years |
| James R. Largent | M | 74 | 6 years | |
| Lisa D. Parr | M | 59 | 3 years | |
| Julian Gangolli | M | 66 | 17 years | |
| Holger Heidrich | M | 71 | 4 years | |
| John Miskimen | M | - |
Western Illinois University
| 4 years |
| George Harrison Talbot | M | 76 |
Cerexa, Inc.
Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA. | 1 years |
| Tsutomu Okimura | M | - | - | |
| Thomas A. Mitro | M | 66 | 22 years | |
| John Gainor | M | - | 5 years | |
| Gary A. Stampanato | M | - |
Western Illinois University
| 4 years |
| Dick Akright | M | 65 |
Western Illinois University
| 4 years |
| Thomas M. Kilroy | M | 66 |
Western Illinois University
| 4 years |
| George Lasezkay | M | 72 | 13 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Dennis Podlesak
- Personal Network